{"id":4403,"date":"2022-07-04T12:14:52","date_gmt":"2022-07-04T10:14:52","guid":{"rendered":"https:\/\/dev.plasmaconcept.de\/monovisc\/"},"modified":"2025-11-20T14:35:12","modified_gmt":"2025-11-20T13:35:12","slug":"monovisc","status":"publish","type":"page","link":"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/","title":{"rendered":"Monovisc"},"content":{"rendered":"<section class=\"l-section wpb_row us_custom_9bd936eb slider_unterseite height_auto width_full\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"g-cols wpb_row arteficalslider via_grid cols_2 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default reversed stacking_default\" style=\"--gap:0px;\"><div class=\"wpb_column vc_column_container us_custom_95304ca2 leftbox has_bg_color\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column us_custom_cd781b90 hide_mobile has_text_color\"><div class=\"wpb_wrapper\"><h1 class=\"slidertypo\">SINGLE-INJECTION THERAPY FOR THE TREATMENT OF OSTEOARTHRITIS PAIN<\/h1>\n<\/div><\/div><div class=\"wpb_text_column us_custom_6df4bc3a has_text_color\"><div class=\"wpb_wrapper\"><p>This FDA approval study shows that MONOVISC\u00ae achieves the greatest reduction in pain compared to baseline, with long-lasting effects. MONOVISC\u00ae relieves pain in knee osteoarthritis for a very long period of at least six months.<\/p>\n<\/div><\/div><div class=\"w-image us_custom_13e4d087 align_none\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"574\" height=\"383\" src=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/12\/monovisc_produktunterseite_slider_produkt-2025-1.png\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/12\/monovisc_produktunterseite_slider_produkt-2025-1.png 574w, https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/12\/monovisc_produktunterseite_slider_produkt-2025-1-300x200.png 300w\" sizes=\"auto, (max-width: 574px) 100vw, 574px\" \/><\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container us_custom_e032691c rightbox has_bg_color\"><div class=\"vc_column-inner\"><div class=\"w-html\"><div class=\"desk-spacer\" style=\"height:500px;\"><\/div>\n<div class=\"mobile-spacer\" style=\"height:0px;\"><\/div><\/div><div class=\"w-html\"><div style=\"clear:both;\"><\/div><\/div><div class=\"w-image us_custom_c3344b39 fda_logo align_right\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"194\" height=\"194\" src=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/07\/FDA_zulassung_zertifikat_slider_plasma.png\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/07\/FDA_zulassung_zertifikat_slider_plasma.png 194w, https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/07\/FDA_zulassung_zertifikat_slider_plasma-150x150.png 150w\" sizes=\"auto, (max-width: 194px) 100vw, 194px\" \/><\/div><\/div><div class=\"w-image us_custom_5051c2af mdr_logo align_right\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"563\" height=\"187\" src=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2025\/09\/Logo-MDR-certified-0725.png\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2025\/09\/Logo-MDR-certified-0725.png 563w, https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2025\/09\/Logo-MDR-certified-0725-300x100.png 300w\" sizes=\"auto, (max-width: 563px) 100vw, 563px\" \/><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row schmallercontentprodukte24 height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column produkt_intro_text\"><div class=\"wpb_wrapper\"><h2>Very high active ingredient content and crosslinking for less pain<\/h2>\n<p>Compared to other single-injection products, MONOVISC\u00ae is supported by a large placebo-controlled, randomized, double-blind, multicenter study. This FDA approval study shows: MONOVISC\u00ae achieves the greatest reduction in pain compared to baseline, with a long-lasting effect. MONOVISC\u00ae relieves pain in knee osteoarthritis for a very long period of at least six months.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_a4fbd29b breiterebloecke height_auto width_full\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_3 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--gap:20px;\"><div class=\"wpb_column vc_column_container highlightboxprodukt mblue\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column produktehighlightbox\"><div class=\"wpb_wrapper\"><h4>Effective<\/h4>\n<ul>\n<li>Single-injection therapy with advanced crosslinking technology for long-lasting residence time in the joint<\/li>\n<li>Very high hyaluronic acid active ingredient content in just one injection (88 mg)<\/li>\n<li>Proven efficacy and safety confirmed by an FDA approval study<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container highlightboxprodukt morange\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column produktehighlightbox\"><div class=\"wpb_wrapper\"><h4>Safe<\/h4>\n<ul>\n<li>Biotechnological manufacturing process through fermentation; free from animal proteins<\/li>\n<li>Extremely high level of purity<\/li>\n<li>Production of the highly purified and sterile hyaluronic acid solution in Boston, USA<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container highlightboxprodukt mgreen\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column produktehighlightbox\"><div class=\"wpb_wrapper\"><h4>Patient-friendly<\/h4>\n<ul>\n<li>Only 1 injection per treatment cycle<\/li>\n<li>Fast and long-lasting pain relief as well as improved joint mobility<\/li>\n<li>Less injection-related stress\/pain for the patient<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row schmallercontentprodukte24 height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-tabs layout_hor style_trendy switch_click\" style=\"--sections-title-size:1em\"><div class=\"w-tabs-list items_3 align_none\"><div class=\"w-tabs-list-h\"><button class=\"w-tabs-item active\" aria-controls=\"content-t196\" aria-expanded=\"false\"><span class=\"w-tabs-item-title\">Proven security<\/span><\/button><button class=\"w-tabs-item\" aria-controls=\"content-q923\" aria-expanded=\"false\"><span class=\"w-tabs-item-title\">High treatment comfort<\/span><\/button><button class=\"w-tabs-item\" aria-controls=\"content-u631\" aria-expanded=\"false\"><span class=\"w-tabs-item-title\">Short and compact<\/span><\/button><\/div><\/div><div class=\"w-tabs-sections titles-align_none icon_chevron cpos_right\"><div class=\"w-tabs-section active\" id=\"t196\"><button class=\"w-tabs-section-header active\" aria-controls=\"content-t196\" aria-expanded=\"true\"><div class=\"w-tabs-section-title\">Proven security<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-t196\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_0f8f44b7\"><div class=\"wpb_wrapper\"><h4>Optimally tolerated, manufactured using a patented biotechnological process<\/h4>\n<\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><ul>\n<li>The six-month FDA approval study involving 369 patients confirms: MONOVISC\u00ae has a low rate of side effects. Only 2.2% mild reactions at the injection site were reported.<sup>5<\/sup> In comparison, another single-injection product with a higher molecular weight shows a side-effect rate of 5.7%.<sup>6<\/sup><\/li>\n<li>MONOVISC\u00ae has an exceptionally high level of purity and is biotechnologically produced through fermentation.<\/li>\n<li>MONOVISC\u00ae contains a highly pure and sterile hyaluronic acid solution. Thanks to its sterile packaging, MONOVISC\u00ae is suitable for use in the operating room.<\/li>\n<li>MONOVISC\u00ae is produced in Boston, USA.<\/li>\n<\/ul>\n<\/div><\/div><div class=\"w-separator size_small with_line width_default thick_1 style_solid color_border align_center\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><h2>PROVEN EFFECTIVENESS \u2013 Fast and long-lasting pain relief<\/h2>\n<\/div><\/div><div class=\"w-image us_custom_ac183423 image_border_content align_none\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"1024\" height=\"461\" src=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik1_produktinformationen_plasmaconcept_juni2019-1024x461-1.jpg\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik1_produktinformationen_plasmaconcept_juni2019-1024x461-1.jpg 1024w, https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik1_produktinformationen_plasmaconcept_juni2019-1024x461-1-300x135.jpg 300w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p class=\"bildunterschrift\">Fig. 1: Reduction of the WOMAC pain score in % over the respective study duration<\/p>\n<\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><ul>\n<li>MONOVISC\u00ae reduces the WOMAC pain score by an average of 45% within six months compared to baseline.<\/li>\n<li>MONOVISC\u00ae demonstrates superior effectiveness in relieving pain in knee osteoarthritis compared to single-injection products with lower active ingredient content. <sup>1,2,3<\/sup><\/li>\n<li>MONOVISC\u00ae provides faster pain relief compared to other single-injection products: the WOMAC pain score decreases by 36% after just two weeks.<\/li>\n<\/ul>\n<\/div><\/div><div class=\"w-separator size_small with_line width_default thick_1 style_solid color_border align_center\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"g-cols wpb_row via_grid cols_2 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--gap:3rem;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image us_custom_35445ed1 image_border_content align_none\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"1024\" height=\"660\" src=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik2_produktinformationen_plasmaconcept_juni2019-1024x660-1.jpg\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik2_produktinformationen_plasmaconcept_juni2019-1024x660-1.jpg 1024w, https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik2_produktinformationen_plasmaconcept_juni2019-1024x660-1-300x193.jpg 300w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p class=\"bildunterschrift\">Fig. 2: Overview of crosslinked hyaluronic acid single-injection products and their hyaluronic acid content<\/p>\n<\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image us_custom_35445ed1 image_border_content align_none\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"1024\" height=\"660\" src=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik3_produktinformationen_plasmaconcept_juni2019-1024x660-1.jpg\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik3_produktinformationen_plasmaconcept_juni2019-1024x660-1.jpg 1024w, https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik3_produktinformationen_plasmaconcept_juni2019-1024x660-1-300x193.jpg 300w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p class=\"bildunterschrift\">Fig. 3: Reduction of the WOMAC pain score depending on the amount of hyaluronic acid used.5<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>MONOVISC\u00ae delivers a high active ingredient content compared to other crosslinked one-shot products available on the market. One injection of 4 ml contains 88 mg of hyaluronic acid at a concentration of 22 mg\/ml.<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"q923\"><button class=\"w-tabs-section-header\" aria-controls=\"content-q923\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">High treatment comfort<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-q923\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_0f8f44b7\"><div class=\"wpb_wrapper\"><h4>Minimized treatment cycle<\/h4>\n<\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><ul>\n<li>Since MONOVISC\u00ae requires only a single injection per treatment cycle, this means less injection-related stress\/pain for the patient.<\/li>\n<li>MONOVISC\u00ae is suitable for all patients who have little time for repeated injections and who value fast and long-lasting effectiveness in their treatment.<\/li>\n<li>MONOVISC\u00ae features an ergonomically optimized syringe for safe and easy injection.<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"u631\"><button class=\"w-tabs-section-header\" aria-controls=\"content-u631\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Short and compact<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-u631\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"g-cols wpb_row via_grid cols_2 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--gap:3rem;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Hyaluronic acid content:<\/strong> 88 mg<br \/>\n<strong>Treatment:<\/strong> 1 injection<br \/>\n<strong>Content:<\/strong> 1 prefilled syringe (4 ml)<br \/>\n<strong>Manufacturing process:<\/strong> Fermentation<br \/>\n<strong>Production:<\/strong> Boston, USA<br \/>\n<strong>Applications:<\/strong> Approved for the knee, hip, shoulder, and ankle joints<br \/>\n<strong>Approval:<\/strong> Medical device with CE marking, MDR approval, and FDA approval<\/p>\n<\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"574\" height=\"383\" src=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/12\/monovisc_produktunterseite_slider_produkt-2025-1.png\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/12\/monovisc_produktunterseite_slider_produkt-2025-1.png 574w, https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2024\/12\/monovisc_produktunterseite_slider_produkt-2025-1-300x200.png 300w\" sizes=\"auto, (max-width: 574px) 100vw, 574px\" \/><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"w-separator size_medium with_line width_default thick_1 style_solid color_border align_center\"><div class=\"w-separator-h\"><\/div><\/div><div class=\"wpb_text_column us_custom_15f9d3f2\"><div class=\"wpb_wrapper\"><h2>More Knowledge, More Movement<\/h2>\n<\/div><\/div><div class=\"w-tabs style_default switch_click accordion\" style=\"--sections-title-size:inherit\"><div class=\"w-tabs-sections titles-align_none icon_chevron cpos_right\"><div class=\"w-tabs-section\" id=\"b832\"><button class=\"w-tabs-section-header\" aria-controls=\"content-b832\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Optimal molecular weight<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-b832\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>Injecting exogenous high\u2013molecular weight hyaluronic acid into the joint can interrupt the osteoarthritic cascade by 1. preventing the production of inflammatory cytokines and enzymes, 2. restoring the production of natural hyaluronic acid, and 3. slowing the progression of osteoarthritis. These effects depend on the molecular weight. There is an optimal molecular weight range that maximizes hyaluronic acid\u2019s ability to interact with the cell surface receptors of synovial cells. This interaction increases the synthesis of natural hyaluronic acid.<\/p>\n<\/div><\/div><div class=\"w-image us_custom_ac183423 image_border_content align_none\"><div class=\"w-image-h\"><img decoding=\"async\" width=\"737\" height=\"420\" src=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik4_hintergrundinformationen_plasmaconcept_juni2019.jpeg\" class=\"attachment-full size-full\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik4_hintergrundinformationen_plasmaconcept_juni2019.jpeg 737w, https:\/\/dev.plasmaconcept.de\/wp-content\/uploads\/2022\/07\/monovisc_infografik4_hintergrundinformationen_plasmaconcept_juni2019-300x171.jpeg 300w\" sizes=\"auto, (max-width: 737px) 100vw, 737px\" \/><\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p class=\"bildunterschrift\">Fig. 4: Effect of hyaluronic acid molecular weight on the interaction with cell surface receptors in osteoarthritic synovial cells<\/p>\n<\/div><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><ul>\n<li>Hyaluronic acid molecules with low molecular weight bind only weakly to surface receptors. This results in little to no stimulation of hyaluronic acid biosynthesis.<\/li>\n<li>Hyaluronic acid molecules with excessively high molecular weight (&gt; 4 million Daltons) cannot adequately bind to surface receptors due to their size. As a result, their ability to stimulate hyaluronic acid biosynthesis is limited.<\/li>\n<li>Hyaluronic acid molecules with an optimal molecular weight (between 500 thousand and 4 million Daltons) bind excellently to surface receptors, thereby maximizing the stimulation of natural hyaluronic acid biosynthesis.<\/li>\n<\/ul>\n<\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><div class=\"wpb_column vc_column_container us_custom_d2199d32\"><div class=\"vc_column-inner\"><\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"nbf4\"><button class=\"w-tabs-section-header\" aria-controls=\"content-nbf4\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Cross-linked and extremely viscous<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-nbf4\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>MONOVISC\u00ae is manufactured using a patented crosslinking process and features a lightly crosslinked molecular structure. The resulting stabilized hyaluronic acid is broken down more slowly and remains in the joint for a longer period of time. MONOVISC\u00ae has a primary effect as a lubricant and shock absorber (it enables smooth gliding of the joint surfaces and, due to its viscoelastic properties, cushions the pressure generated under load). In addition, MONOVISC\u00ae is integrated into the cartilage matrix and stimulates the body\u2019s own production of hyaluronic acid.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"SINGLE-INJECTION THERAPY FOR THE TREATMENT OF OSTEOARTHRITIS PAIN This FDA approval study shows that MONOVISC\u00ae achieves the greatest reduction in pain compared to baseline, with long-lasting effects. MONOVISC\u00ae relieves pain in knee osteoarthritis for a very long period of at least six months. Very high active ingredient content and crosslinking for less pain Compared to...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-4403","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Plasmaconcept - Monovisc: Einzelinjektions-Therapie bei Arthrose<\/title>\n<meta name=\"description\" content=\"MONOVISC\u00ae erreicht im Vergleich zur Baseline die gr\u00f6\u00dfte Schmerzreduktion mit einer dauerhaften Wirkung. MONOVISC\u00ae lindert die Schmerzen bei...\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Plasmaconcept - Monovisc: Einzelinjektions-Therapie bei Arthrose\" \/>\n<meta property=\"og:description\" content=\"MONOVISC\u00ae erreicht im Vergleich zur Baseline die gr\u00f6\u00dfte Schmerzreduktion mit einer dauerhaften Wirkung. MONOVISC\u00ae lindert die Schmerzen bei...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/\" \/>\n<meta property=\"og:site_name\" content=\"Plasmaconcept\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-20T13:35:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/\",\"url\":\"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/\",\"name\":\"Plasmaconcept - Monovisc: Einzelinjektions-Therapie bei Arthrose\",\"isPartOf\":{\"@id\":\"https:\/\/dev.plasmaconcept.de\/en\/#website\"},\"datePublished\":\"2022-07-04T10:14:52+00:00\",\"dateModified\":\"2025-11-20T13:35:12+00:00\",\"description\":\"MONOVISC\u00ae erreicht im Vergleich zur Baseline die gr\u00f6\u00dfte Schmerzreduktion mit einer dauerhaften Wirkung. MONOVISC\u00ae lindert die Schmerzen bei...\",\"breadcrumb\":{\"@id\":\"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/dev.plasmaconcept.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Monovisc\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dev.plasmaconcept.de\/en\/#website\",\"url\":\"https:\/\/dev.plasmaconcept.de\/en\/\",\"name\":\"Plasmaconcept\",\"description\":\"Nah am Markt und nah am Menschen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dev.plasmaconcept.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Plasmaconcept - Monovisc: Einzelinjektions-Therapie bei Arthrose","description":"MONOVISC\u00ae erreicht im Vergleich zur Baseline die gr\u00f6\u00dfte Schmerzreduktion mit einer dauerhaften Wirkung. MONOVISC\u00ae lindert die Schmerzen bei...","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Plasmaconcept - Monovisc: Einzelinjektions-Therapie bei Arthrose","og_description":"MONOVISC\u00ae erreicht im Vergleich zur Baseline die gr\u00f6\u00dfte Schmerzreduktion mit einer dauerhaften Wirkung. MONOVISC\u00ae lindert die Schmerzen bei...","og_url":"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/","og_site_name":"Plasmaconcept","article_modified_time":"2025-11-20T13:35:12+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/","url":"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/","name":"Plasmaconcept - Monovisc: Einzelinjektions-Therapie bei Arthrose","isPartOf":{"@id":"https:\/\/dev.plasmaconcept.de\/en\/#website"},"datePublished":"2022-07-04T10:14:52+00:00","dateModified":"2025-11-20T13:35:12+00:00","description":"MONOVISC\u00ae erreicht im Vergleich zur Baseline die gr\u00f6\u00dfte Schmerzreduktion mit einer dauerhaften Wirkung. MONOVISC\u00ae lindert die Schmerzen bei...","breadcrumb":{"@id":"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.plasmaconcept.de\/en\/monovisc\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.plasmaconcept.de\/en\/monovisc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/dev.plasmaconcept.de\/en\/"},{"@type":"ListItem","position":2,"name":"Monovisc"}]},{"@type":"WebSite","@id":"https:\/\/dev.plasmaconcept.de\/en\/#website","url":"https:\/\/dev.plasmaconcept.de\/en\/","name":"Plasmaconcept","description":"Nah am Markt und nah am Menschen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.plasmaconcept.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/dev.plasmaconcept.de\/en\/wp-json\/wp\/v2\/pages\/4403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.plasmaconcept.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.plasmaconcept.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.plasmaconcept.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.plasmaconcept.de\/en\/wp-json\/wp\/v2\/comments?post=4403"}],"version-history":[{"count":4,"href":"https:\/\/dev.plasmaconcept.de\/en\/wp-json\/wp\/v2\/pages\/4403\/revisions"}],"predecessor-version":[{"id":4587,"href":"https:\/\/dev.plasmaconcept.de\/en\/wp-json\/wp\/v2\/pages\/4403\/revisions\/4587"}],"wp:attachment":[{"href":"https:\/\/dev.plasmaconcept.de\/en\/wp-json\/wp\/v2\/media?parent=4403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}